News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
189,445 Results
Type
Article (14320)
Company Profile (22)
Press Release (175103)
Multimedia
Podcasts (15)
Webinars (2)
Section
Business (51753)
Career Advice (498)
Deals (6705)
Drug Delivery (49)
Drug Development (23275)
Employer Resources (41)
FDA (4833)
Job Trends (5219)
News (89250)
Policy (11258)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (2)
2024 Biotech Bay Standard (2)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (1)
Academia (1656)
Academic (1)
Accelerated approval (3)
Adcomms (8)
Allergies (22)
Alliances (15145)
ALS (31)
Alzheimer's disease (603)
Antibody-drug conjugate (ADC) (24)
Approvals (4897)
Artificial intelligence (71)
Autoimmune disease (9)
Automation (2)
Bankruptcy (64)
Best Places to Work (4714)
BIOSECURE Act (15)
Biosimilars (30)
Biotechnology (17)
Bladder cancer (22)
Brain cancer (9)
Breast cancer (96)
Cancer (750)
Cardiovascular disease (72)
Career advice (427)
Career pathing (7)
CAR-T (36)
Cell therapy (113)
Cervical cancer (15)
Clinical research (18811)
Collaboration (266)
Compensation (30)
Complete response letters (1)
COVID-19 (1225)
CRISPR (18)
C-suite (77)
Cystic fibrosis (62)
Data (732)
Decentralized trials (1)
Denatured (7)
Depression (5)
Diabetes (100)
Diagnostics (2114)
Digital health (9)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (29)
Drug pricing (39)
Drug shortages (5)
Duchenne muscular dystrophy (28)
Earnings (13729)
Editorial (16)
Employer branding (6)
Employer resources (34)
Events (23389)
Executive appointments (231)
FDA (5290)
Featured Employer (10)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (317)
Gene editing (31)
Generative AI (8)
Gene therapy (72)
GLP-1 (207)
Government (2764)
Grass and pollen (1)
Guidances (17)
Healthcare (8064)
IgA nephropathy (26)
Immunology and inflammation (19)
Indications (11)
Infectious disease (1278)
Inflammatory bowel disease (39)
Inflation Reduction Act (2)
Influenza (19)
Intellectual property (28)
Interviews (75)
IPO (3095)
IRA (13)
Job creations (665)
Job search strategy (376)
Kidney cancer (10)
Labor market (9)
Layoffs (73)
Leadership (4)
Legal (2017)
Liver cancer (17)
Lung cancer (105)
Lymphoma (53)
Machine learning (3)
Management (13)
Manufacturing (84)
MASH (14)
Medical device (3061)
Medtech (3062)
Mergers & acquisitions (3721)
Metabolic disorders (200)
Multiple sclerosis (20)
NASH (3)
Neurodegenerative disease (23)
Neuropsychiatric disorders (1)
Neuroscience (771)
NextGen: Class of 2025 (2974)
Non-profit (3934)
Northern California (642)
Now hiring (5)
Obesity (88)
Opinion (70)
Ovarian cancer (18)
Pain (29)
Pancreatic cancer (21)
Parkinson's disease (70)
Partnered (6)
Patents (58)
Patient recruitment (38)
Peanut (12)
People (18794)
Pharmaceutical (6)
Pharmacy benefit managers (6)
Phase I (5203)
Phase II (8106)
Phase III (6935)
Pipeline (361)
Policy (60)
Postmarket research (852)
Preclinical (2183)
Press Release (19)
Prostate cancer (37)
Psychedelics (3)
Radiopharmaceuticals (78)
Rare diseases (154)
Real estate (1509)
Recruiting (16)
Regulatory (7361)
Reports (9)
Research institute (1477)
Resumes & cover letters (66)
RSV (16)
Schizophrenia (22)
Series A (45)
Series B (26)
Sickle cell disease (21)
Southern California (560)
Special edition (2)
Spinal muscular atrophy (95)
Sponsored (10)
Startups (1029)
State (1)
Stomach cancer (1)
Supply chain (24)
Tariffs (12)
The Weekly (7)
United States (6000)
Vaccines (242)
Venture capitalists (10)
Weight loss (58)
Women's health (11)
Worklife (3)
Date
Today (33)
Last 7 days (125)
Last 30 days (617)
Last 365 days (9205)
2025 (2589)
2024 (9784)
2023 (11428)
2022 (14884)
2021 (16708)
2020 (17837)
2019 (18208)
2018 (13433)
2017 (8477)
2016 (8822)
2015 (9775)
2014 (7341)
2013 (5801)
2012 (6185)
2011 (6637)
2010 (5264)
Location
Africa (286)
Alabama (11)
Alaska (3)
Arizona (59)
Arkansas (7)
Asia (11295)
Australia (1824)
California (1418)
Canada (545)
China (260)
Colorado (81)
Connecticut (86)
Delaware (56)
Europe (20234)
Florida (240)
Georgia (64)
Idaho (16)
Illinois (181)
India (11)
Indiana (97)
Iowa (3)
Japan (67)
Kansas (29)
Kentucky (13)
Louisiana (4)
Maine (7)
Maryland (369)
Massachusetts (925)
Michigan (45)
Minnesota (82)
Mississippi (2)
Missouri (51)
Montana (11)
Nebraska (9)
Nevada (32)
New Hampshire (22)
New Jersey (599)
New Mexico (11)
New York (459)
North Carolina (245)
North Dakota (1)
Northern California (642)
Ohio (60)
Oklahoma (4)
Oregon (7)
Pennsylvania (324)
Puerto Rico (1)
Rhode Island (9)
South America (322)
South Carolina (8)
South Dakota (1)
Southern California (560)
Tennessee (35)
Texas (242)
Utah (45)
Virginia (46)
Washington D.C. (20)
Washington State (135)
West Virginia (2)
Wisconsin (20)
189,445 Results for "national kidney foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Palatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring Meeting
April 11, 2025
·
7 min read
Press Releases
Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings
April 11, 2025
·
5 min read
Pharm Country
National Kidney Foundation Recognizes March as National Kidney Month
As March approaches, the National Kidney Foundation is gearing up to observe National Kidney Month, a crucial time dedicated to raising awareness about kidney health and chronic kidney disease.
February 29, 2024
·
5 min read
Press Releases
Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the National Kidney Foundation Spring Clinical Meetings 2025
March 31, 2025
·
15 min read
Press Releases
Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings
April 1, 2025
·
4 min read
BioCapital
The National Kidney Foundation Urges Passage of New Home Dialysis Bill
The National Kidney Foundation is applauding a move by Congress to increase access to care and improve outcomes for some patients on dialysis.
April 23, 2024
·
5 min read
Press Releases
Eascra Biotech Receives U.S. National Science Foundation Grant
April 21, 2025
·
2 min read
Biotech Beach
Promising Findings on Kidney Function Preservation in IgA Nephropathy Patients at National Kidney Foundation Spring Clinical Meetings
A new study to shed light on the long-term nephroprotective potential of sparsentan compared to maximally titrated irbesartan in patients with IgA nephropathy is set to be presented as a late-breaking presentation at the annual 2024 National Kidney Foundation Spring Clinical Meetings this week in Long Beach, CA.
May 16, 2024
·
3 min read
Biotech Beach
New Analysis on Hypertension Treatment to be Presented as Late-Breaking Research at National Kidney Foundation Spring Clinical Meetings
A new analysis of a study comparing two commonly used medications, chlorthalidone and hydrochlorothiazide, is set to be presented as a late-breaking presentation at the annual 2024 National Kidney Foundation Spring Clinical Meetings.
May 16, 2024
·
3 min read
Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation’s Spring Clinical Meeting 2024
Aurinia Pharmaceuticals Inc., announced the presentation of results from an updated cost-effective analysis of LUPKYNIS, a second generation calcineurin inhibitor, at the annual National Kidney Foundation Spring Clinical Meeting 2024 taking place in Long Beach, CA, May 14-18.
May 14, 2024
·
11 min read
1 of 18,945
Next
